References
- Witzig T E, Maurer M J, Johnston P B, Colgan J P, Kaufmann S H, Inwards D I, et al. Oral tipifarnib (R115777) has single agent anti-tumor activity in patients with relapsed aggressive non-Hodgkin lymphoma (NHL): results of a phase II trial in the University of Iowa/Mayo Clinic Lymphoma SPORE (CA97274). Blood (Suppl.) 2006; 108: 530
- Wiernik P H, Lossos I, Tuscano J, Justice G, Vose J M, Pietronigro D, et al. Preliminary results from a phase II study of lenalidomide monotherapy in relapsed/refractory aggressive non-Hodgkin's lymphoma. Blood (Suppl.) 2006; 108: 531
- List A, Kurtin S, Roe D J, Buresh A, Mahadevan D, Fuchs D, et al. Efficacy of lenalidomide in myelodysplastic syndromes. N Engl J Med 2005; 352: 549–557
- Baz R, Walker E, Karam M A, Choueiri T K, Jawde R A, Bruening L, et al. Lenalidomide and pegylated liposomal doxorubicin-based chemotherapy for relapsed or refractory multiple myeloma: safety and efficacy. Ann Oncol 2006; 17: 1766–1771
- Dispenzieri A, Lacy M Q, Zeldenrust S R, Hayman S R, Kumar S K, Geyer S M, et al. The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis. Blood 2007; 109: 465–470
- Toni K, Choueiri R D, Rini B I, Elson P, Garcia J A, Thakkar S G, et al. Phase II study of lenalidomide in patients with metastatic renal cell carcinoma. Cancer 2006; 107: 2609–2616
- Badros A Z, Siegel E, Bodenner, Zangari M, Zeldis J, Barlogie B, et al. Hypothyroidism in patients with multiple myeloma following treatment with thalidomide. Am J Med 2002; 112: 412–413
- Stein E M, Rivera C. Transient thyroiditis after treatment with lenalidomide in a patient with metastatic renal cell carcinoma. Thyroid 2007; 17: 681–683
- Chow L QM, Eckhardt G. Sunitinib: from rational design to clinical efficacy. J Clin Oncol 2007; 25: 884–896
- Desai J, Yassa L, Marqusee E, George S, Frates M C, Chen M H, et al. Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors. Ann Intern Med 2006; 145: 660–664
- Rini B I, Tamaskar I, Shaheen P, Salas R, Garcia J, Wood L, et al. Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib. J Natl Cancer Inst 2007; 99: 81–83
- Teo S K. Properties of thalidomide and its analogues: implications for anticancer therapy. AAPS J 2005; 7: E14–E19
- Schwartzentruber D J, White D E, Zweig M H, Weintraub B D, Rosenberg S A. Thyroid dysfunction associated with immunotherapy for patients with cancer. Cancer 1991; 68: 2384–2390
- Steensma D P, Witzig T E. Elevated serum LDH in patients with non-Hodgkin's lymphoma: not always an ominous sign. Br J Haematol 1999; 107: 463–464
- Kreisman S H, Hennessey J V. Consistent reversible elevations of serum creatinine levels in severe hypothyroidism. Arch Intern Med 1999; 159: 79–82